Boston Scientific (BSX) FCF Margin (2009 - 2026)
Boston Scientific recorded quarterly FCF Margin of 3.29% in Q1 2026, down 82.85% quarter-over-quarter from 19.16% in Q4 2025, and down 431.0% year-over-year from 0.99% in Q1 2025.
Boston Scientific's FCF Margin history runs 18 years deep, the most recent figure standing at 3.29% for Q1 2026.
- In Q1 2026, FCF Margin fell 431.0% year-over-year to 3.29%; the TTM figure through Mar 2026 stood at 16.86% (down 31.0% YoY), while the FY2025 annual figure was 18.22%, up 243.0% from the prior year.
- FCF Margin came in at 3.29% for Q1 2026 at Boston Scientific, down from 19.16% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 25.85% in Q4 2024 to a low of 5.92% in Q1 2022.
- A 5-year average of 12.62% and a median of 14.4% in 2023 frame the typical range for FCF Margin.
- On a YoY basis, FCF Margin climbed as much as 1157 bps in 2022 and fell as far as 1351 bps in 2022.
- Boston Scientific's FCF Margin stood at 18.35% in 2022, then increased by 1 bps to 18.52% in 2023, then surged by 40 bps to 25.85% in 2024, then declined by 26 bps to 19.16% in 2025, then tumbled by 83 bps to 3.29% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 3.29%, 19.16%, and 22.94% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 15.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.29% |
| Dec 31, 2025 | 19.16% |
| Sep 30, 2025 | 22.94% |
| Jun 30, 2025 | 22.31% |
| Mar 31, 2025 | 7.59% |
| Dec 31, 2024 | 25.85% |
| Sep 30, 2024 | 19.55% |
| Jun 30, 2024 | 15.97% |
| Mar 31, 2024 | -0.39% |
| Dec 31, 2023 | 18.52% |
| Sep 30, 2023 | 14.40% |
| Jun 30, 2023 | 14.31% |
| Mar 31, 2023 | 2.33% |
| Dec 31, 2022 | 18.35% |
| Sep 30, 2022 | 10.09% |
| Jun 30, 2022 | 6.23% |
| Mar 31, 2022 | -5.92% |
| Dec 31, 2021 | 6.78% |
| Sep 30, 2021 | 12.21% |
| Jun 30, 2021 | 17.45% |
| Mar 31, 2021 | 7.59% |
| Dec 31, 2020 | 18.97% |
| Sep 30, 2020 | 22.34% |
| Jun 30, 2020 | 10.03% |
| Mar 31, 2020 | -6.96% |
| Dec 31, 2019 | 17.42% |
| Sep 30, 2019 | 14.07% |
| Jun 30, 2019 | 7.64% |
| Mar 31, 2019 | 11.51% |
| Dec 31, 2018 | -3.40% |
| Sep 30, 2018 | 17.76% |
| Jun 30, 2018 | -19.16% |
| Mar 31, 2018 | 5.59% |
| Dec 31, 2017 | 25.12% |
| Sep 30, 2017 | 17.64% |
| Jun 30, 2017 | 10.15% |
| Mar 31, 2017 | -5.51% |
| Dec 31, 2016 | 23.23% |
| Sep 30, 2016 | -4.85% |
| Jun 30, 2016 | 16.13% |
| Mar 31, 2016 | 2.85% |
| Dec 31, 2015 | 16.94% |
| Sep 30, 2015 | 17.90% |
| Jun 30, 2015 | 0.76% |
| Mar 31, 2015 | -13.74% |
| Dec 31, 2014 | 19.13% |
| Sep 30, 2014 | 15.71% |
| Jun 30, 2014 | 11.75% |
| Mar 31, 2014 | 7.84% |
| Dec 31, 2013 | 10.39% |
| Sep 30, 2013 | 11.18% |
| Jun 30, 2013 | 19.13% |
| Mar 31, 2013 | 7.61% |
| Dec 31, 2012 | 17.96% |
| Sep 30, 2012 | 13.03% |
| Jun 30, 2012 | 19.42% |
| Mar 31, 2012 | 7.82% |
| Dec 31, 2011 | 14.39% |
| Sep 30, 2011 | 15.85% |
| Jun 30, 2011 | 15.54% |
| Mar 31, 2011 | -8.62% |
| Dec 31, 2010 | 19.28% |
| Sep 30, 2010 | -10.65% |
| Jun 30, 2010 | 11.67% |
| Mar 31, 2010 | -18.06% |
| Dec 31, 2009 | -20.01% |
| Sep 30, 2009 | 19.41% |
| Jun 30, 2009 | 16.63% |
| Mar 31, 2009 | 10.00% |